Palvella Therapeutics Announces Series D Financing of Up to $37.7 Million
Palvella Therapeutics Announces Series D Financing of Up to $37.7 Million to Accelerate Late-Stage Development and Support...
Palvella Therapeutics Announces Series D Financing of Up to $37.7 Million
Financial Expert, Charmaine Tang, joins Gore Range Capital as Industry Advisor
Renowned Dermatologist - Dr. Matt Leavitt joins Gore Range Capital as an Executive Partner
Gore Range Capital Congratulates Dr. Seemal Desai, 2024 President of the AAD
Announcing Our Newest Team Member, Chidi Nwankpa, MD, MBA
Why this VC moved his firm to North Texas to launch its second fund (Video)
An Inside Look at a VC’s Priorities when Evaluating Potential Investments
Ethan Rigel Discusses Gore Range's Skin Health Fund and New Base in Dallas, TX
Gore Range Capital Adds Seven Industry Leaders as New Advisors for Fund II
Proud to support this year's Hacking Dermatology as a sponsor and mentor
Maternity management company Dorsata scores $5.2M in Series A funding
LEO Pharma Joins Gore Range Capital as Strategic Investor
Gore Range Capital Closes Debut Fund